Development of a single index of risk for the development metachronous neoplastic lesions in resected colorectal cancer;Elaboración de un índice individual del riesgo para el desarrollo de lesiones neoplásicas metacrónicas en el cáncer colorrectal resecado

Revista Espanola de Enfermedades Digestivas

Volumn 104, Issue 6, 2012, Pages 291-297

  Borda, Ana ^a   Martínez Peñuela, José María ^a   Borda, Fernando ^a   Muñoz Navas, Miquel ^b   Jiménez, Francisco Javier ^a   Carretero, Cristina ^b  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Colorectal cancer; Follow up; Metachronous lesions

Indexed keywords

MUCIN; MUCIN 5; UNCLASSIFIED DRUG;

ADENOMA; ADULT; ALCOHOL CONSUMPTION; CANCER PROGNOSIS; COLORECTAL CANCER; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; METACHRONOUS NEOPLASTIC LESION; NEOPLASM; PREDICTIVE VALUE; REVIEW; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; AGED; ARTICLE; COLONOSCOPY; COLORECTAL TUMOR; DECISION SUPPORT SYSTEM; EVALUATION; MIDDLE AGED; MULTIPLE CANCER; MULTIVARIATE ANALYSIS; PROGNOSIS; RISK ASSESSMENT; SECOND CANCER; STATISTICAL MODEL;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; DECISION SUPPORT TECHNIQUES; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84863302897     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082012000600002     Document Type: Review

References (45)

1. Tárraga-López PJ. Should we prevent colorectal cancer? Rev Esp Enferm Dig 2011;103:503-7.
2. Binefa-Rodríguez G. Colorectal cancer mortality trends in Spain. What shall we do? Rev Esp Enferm Dig 2011;103:285-8.
3. Piñol V, Andreu M, Castells A, Paya A, Bessa X, Jover R. Synchronous colorectal neoplasms in patients with colorectal cancer: predisposing individual and familial factors. Dis Colon Rectum 2004;47:1192-2000.
4. Borda A, Martínez-Peñuela JM, Muñoz-Navas M, Prieto C, Betés M, Borda F. Synchronous neoplastic lesions in colorectal cancer. An analysis of possible risk factors favouring presentation. Rev Esp Enferm Dig 2008;100:139-45.
5. Van Stolk RW, Beck GJ, Baron JA, Haile R, Summers R. Polyp Prevention Study Group. Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up. Gastroenterology 1998;115:13-8.
6. Chung DC, Rustgi AK. DNA mismatch repair and cancer. Gastroenterology 1995;109:1685-99.
7. Karoui M, Tresallet C, Brouquet A, Radvanyi H, Penna C. Colorectal carcinogenesis.1. Hereditary predisposition and colorectal cancer. J Chir 2007;144:13-8.
8. Ballesté B, Bessa X, Piñol V, Castellví-Bel S, Castells A, Alenda C, et al. Detection of metachronous neoplasm in the colorectal cancer patients. Identification of risk factors. Dis Colon Rectum 2007;50:971-80.
9. Perea J, Lomas M, Hidalgo M. Molecular basis of colorrectal cancer: towards an individualized management? Rev Esp Enferm Dig 2011;103:29-35.
10. Bonithon-Kopp C, Fenger PF, Cabeza E, O'Morain C, Kronborg O, Faivre J. Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum 2004;47:323-33.
11. Saini SD, Kim HM, Schoenfeld P. Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review. Gastrointest Endosc 2006;64:614-26.
12. Martinez ME, Baron BA, Lieberman DA, Schatzkin A, Lanza E, Winawer SJ, et al. A pooled analysis of advanced colo-rectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 2009;136:832-41.
13. Moon CM, Cheon JH, Choi EH, Kim ES, Park JJ, Han SY, et al. Advanced synchronous adenoma but not simple adenoma predicts the future development of metachronous neoplasia in patients with resected colorectal cancer. J Clin Gastroenterol 2010;44:495-501.
14. Bouvier AM, Latournerie M, Jooste V, Lepage C, Cottet V, Faivre J. The lifelong risk of metachronous colorectal cancer justifies long-term colonoscopic follow-up. Eur J Cancer 2008;44:522-7.
15. Rajaratnam SG, Dennett ER. Development of metachronous neoplams after colorrectal cancer resection: absence of synchronous neoplams predicts a lower risk. N Z Med J 2009;122:61-6.
16. Erenay FS, Alagoz A, Banerjee R, Cima RR. Estimating the unknown parameters of the natural history of metachronous colorectal cancer using discrete-event simulation. Med Decis Making 2011;31:611-24.
17. Fukutomi Y, Moriwaki H, Nagase S, Tajika M, Naito T, Miwa Y, et al. Metachronous colon tumors: risk factors and rationale for the surveillance colonoscopy after initial polypectomy. J Cancer Res Clin Oncol 2002;128:569-74.
18. Griffioen G, Bosman FT, Verspaget HW, Sier KF, Biemond I, Lamers CB. Comparative evaluation of carcinoembryonic antigen, secretory component, and mucins in index and metachronous adenomas of the colorectum. Gastroenterology 1991;101:919-26.
19. Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2006;130:1865-71.
20. Tjandra JJ, Chan MK. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum 2007;50:1783-99.
21. Prevención del cáncer colorrectal. Guía de Práctica Clínica. Grupo de trabajo de la guía de práctica clínica de prevención del cáncer colorrectal. Actualización 2009. Asociación Española de Gastroenterología, Sociedad Española de Medicina de Familia y Comunitaria, y Centro Cochrane Iberoamericano. Programa de Elaboración de Guías de Práctica Clínica en Enfermedades Digestivas, desde la Atención Primaria a la Especializada: 4. Barcelona: Elsevier España, S.L.; 2009.
22. Søreide K. Endoscopic surveillance after curative surgery for sporadic colorectal cancer: patient tailored, tumor targeted or biology-driven? Scand J Gastroenterol 2010;45:1255-61.
23. Demeter JG, Freeark RJ. The role of prophylactic subtotal colectomy in metachronous carcinoma of the colon and rectum. Surg Gynecol Obstet 1992;175:1-7.
24. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (IGCHNPCC). Dis Colon Rectum 1991;34:424-5.
25. Vasen HF, Watson P, Mecklin JP, Lynch HT. New Clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch Syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999;116:1453-6.
26. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, et al. Revised Bethesda Guidelines for hereditary non-polyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261-8.
27. Greene FL, Page DL, Fleming ID, editors. AJCC (American Joint Committee on Cancer) Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002. p. 113.
28. Shitoh K, Konishi F, Miyakura Y, Togashi K, Okamoto T, Nagai H. Microsatellite instability as a marker in predicting metachronous multiple colorectal carcinomas after surgery: a cohort-like study. Dis Colon Rectum 2002;45:329-33.
29. Cho JH, Lee SK, Kim TI, Kim WH. Characteristics and risk factors of synchronous and metachronous polyp in colorectal cancer. Korean J Gastroenterol 2004;43:168-75.
30. Masubuchi S, Konishi F, Togashi K, Okamoto T, Senba S, Shitoh K, et al. The significance of microsatellite instability in predicting the development of metachronous multiple colorectal carcinomas in patients with non-familial colorectal carcinoma. Cancer 1999;85:1917-24.
31. Tsantilas D, Ntinas A, Petras P, Zambas N, Al Mogrambi S, Frangandreas S, et al. Metachronous colorectal adenocarcinomas. Tech Coloproctol 2004;8:202-4.
32. Rennert G, Robinson E, Rennert HS, Neugut AI. Clinical characteristics of metachronous colorectal tumors. Int J Cancer 1995;60:743-7.
33. Mizoue T, Tanaka K, Tsuji I, Wakai K, Nagata C, Otani T, et al. Alcohol drinking and colorectal cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol 2006;36:582-97.
34. Otani T, Iwasaki M, Yamamoto S, Sobue T, Hanaoka T, Inoue M, et al. Alcohol consumption, smoking, and subsequent risk of colorectal cancer in middle-aged and elderly Japanese men and women: Japan Public Health Center-based prospective study. Cancer Epidemiol Biomarkers Prev 2003;12:1492-500.
35. Jacobson JS, Neugut AI, Murray T, Garbowski GC, Forde KA, Treat MR, et al. Cigarette smoking and other behavioral risk factors to recurrence of colorectal adenomatous polyps (New York City, NY, USA). Cancer Causes Control 1994;5:215-20
36. Yamazaki T, Takii Y, Okamoto H, Sakai Y, Hatakeyama K. What is the risk factor for metachronous colorectal carcinoma? Dis Colon Rectum 1997;40:935-8.
37. Gervaz P, Bucher P, Neyroud-Caspar I, Soravia C, Morel P. Proximal location of colon cancer is a risk factor for the development of metachronous colorectal cancer: a population-based study. Dis Colon Rectum 2005;48:227-32.
38. Legget BA, Cornwell M, Thomas LR, Buttenshaw RL, Searle J, Young J, et al. Characteristics of metachronous colorectal carcinoma occurring despite colonoscopic surveillance. Dis Colon Rectum 1997;40:603-8.
39. Lan YT, Lin JK, Li AF, Lin TC, Chen WS, Jiang JK, et al. Metachronous colorectal cancer: Necessity of post-operative colonoscopic surveillance. Int J Colorectal Dis 2005;20:121-5.
40. Nusko G, Hahn EG, Mansmann U. Characteristics of metachronous colorectal adenomas found during long-term follow-up: analysis of four subsequent generations of adenoma recurrence. Scand J Gastroenterol 2009;44:736-44.
41. Yamaji Y, Mitsushima T, Yoshida H, Watabe H, Okamoto M, Ikuma H. et al Right-sided shift of metachronous colorectal adenomas after polypectomy. Scand J Gastroenterol 2007;42:1466-72.
42. Noshirwani KC, van Stolk RU, Rybicki LA, Beck GJ. Adenoma size and number are predictive of adenoma recurrence: implications for surveillance colonoscopy. Gastrointest Endosc 2000;51:433-7.
43. Demetriades H, Kanellos I, Blouhos K, Tsachalis T, Vasiliadis K, Pramateftakis MG, et al. Synchronous polyps in patients with colorectal cancer. Tech Coloproctol 2004;8:72-5.
44. Chivukula M, Bhargava R, Dabbs DJ. Diagnostic, theragnostic and genomic immunohistochemistry: Standardization issues. Adv Anat Pathol 2008;15:302-4.
45. Lee WS, Park S, Lee WY, Yun SH, Chun HK. Clinical impact of tumorinfiltrating lymphocytes for survival in stage II colon cancer. Cancer 2010;116:188-99.